Aptamer-functionalized peptide H(3)CR(5)C as a novel nanovehicle for codelivery of fasudil and miRNA-195 targeting hepatocellular carcinoma

Liver cancer is the fifth most commonly diagnosed malignancy, of which hepatocellular carcinoma (HCC) represents the dominating histological subtype. Antiangiogenic therapy aimed at vascular endothelial growth factor (VEGF) has shown promising but deficient clinical prospects on account of vasculoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Wu, Xin, Gao, Yuan, Zhang, Jigang, Zhang, Dandan, Gu, Shengying, Zhu, Guanhua, Liu, Gaolin, Li, Xiaoyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990390/
https://www.ncbi.nlm.nih.gov/pubmed/27574422
http://dx.doi.org/10.2147/IJN.S108128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4990390/
https://www.ncbi.nlm.nih.gov/pubmed/27574422
http://dx.doi.org/10.2147/IJN.S108128

Ejemplares similares